The Philadelphia Eagles will not face any disciplinary action from the National Football League regarding their handling of quarterback Jalen Hurts’ medical condition, according to a league spokesperson.
In a statement released on Tuesday, the NFL confirmed that league officials maintained ongoing communication with both Eagles medical personnel and the Cleveland Clinic in London as Hurts underwent treatment. Dr. Allen Sills, the league’s chief medical officer, coordinates with leading providers across international markets to ensure medical resources are available, operating with approval from the NFL Players Association. The league emphasized that player medical care is administered directly by club medical staff in coordination with independent physicians.
Dr. Sills and other league officials were scheduled to address reporters at the league’s annual fall meeting in New York on Tuesday.
Hurts has been placed on injured reserve and is expected to miss the remainder of the season after a blood clot in his left calf traveled to his lungs. The Eagles and the quarterback’s agent, Nicole Lynn, disclosed on Monday that Hurts is suffering from deep vein thrombosis and bilateral pulmonary emboli.
Because his current medical treatment involves blood thinners, Hurts is barred from participating in any football activities until he is fully cleared off the medication.
The timeline of the medical emergency began when Hurts played in a game in London against the Jacksonville Jaguars on Oct. 11. That appearance came three days after the quarterback first informed medical staff of the injury following a practice session. Upon arriving in London, he received an initial diagnosis from specialists who identified a left calf superficial vein thrombosis.
